Works about CENTRAL nervous system diseases


Results: 5000
    1
    2
    3
    4
    5
    6
    7
    8
    9

    The Sphingolipid Receptor S1PR2 Is a Receptor for Nogo-A Repressing Synaptic Plasticity.

    Published in:
    PLoS Biology, 2014, v. 12, n. 1, p. 1, doi. 10.1371/journal.pbio.1001763
    By:
    • Kempf, Anissa;
    • Tews, Bjoern;
    • Arzt, Michael E.;
    • Weinmann, Oliver;
    • Obermair, Franz J.;
    • Pernet, Vincent;
    • Zagrebelsky, Marta;
    • Delekate, Andrea;
    • Iobbi, Cristina;
    • Zemmar, Ajmal;
    • Ristic, Zorica;
    • Gullo, Miriam;
    • Spies, Peter;
    • Dodd, Dana;
    • Gygax, Daniel;
    • Korte, Martin;
    • Schwab, Martin E.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17

    Research Roundup.

    Published in:
    Brown University Psychopharmacology Update, 2018, v. 29, n. 2, p. 7, doi. 10.1002/pu.30297
    Publication type:
    Article
    18
    19
    20
    21
    22
    23

    Promising treatment results with blood brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL).

    Published in:
    Journal of Neuro-Oncology, 2017, v. 131, n. 2, p. 293, doi. 10.1007/s11060-016-2293-8
    By:
    • Kuitunen, Hanne;
    • Tokola, Susanna;
    • Siniluoto, Topi;
    • Isokangas, Matti;
    • Sonkajärvi, Eila;
    • Alahuhta, Seppo;
    • Turpeenniemi-Hujanen, Taina;
    • Jantunen, Esa;
    • Nousiainen, Tapio;
    • Vasala, Kaija;
    • Kuittinen, Outi
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50